Rankings
▼
Calendar
ZTS FY 2011 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
FY 2011 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.2B
+18.2% YoY
Gross Profit
$2.5B
60.0% margin
Operating Income
$684M
16.2% margin
Net Income
$245M
5.8% margin
EPS (Diluted)
$0.51
Cash Flow
Operating Cash Flow
$497M
Free Cash Flow
$362M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$5.7B
Total Liabilities
$2.0B
Stockholders' Equity
$3.7B
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.2B
$3.6B
+18.2%
Gross Profit
$2.5B
$2.1B
+21.7%
Operating Income
$684M
$309M
+121.4%
Net Income
$245M
$110M
+122.7%
← FY 2010
All Quarters
FY 2012 →